194 filings
Page 8 of 10
8-K
hlmp97c47zk
11 Aug 16
Neos Therapeutics Announces Second Quarter 2016 Financial Results
12:00am
CORRESP
0rnjg8 fxpo
10 Aug 16
Correspondence with SEC
12:00am
UPLOAD
l2zgmda1qz4rnq
9 Aug 16
Letter from SEC
12:00am
S-3
bf08q7ephb6p6 ivg
1 Aug 16
Shelf registration
12:00am
8-K
vso p5o2zn3muyb1c89c
28 Jul 16
Other Events
12:00am
8-K
zn41769tn4or
16 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
sj95m7b jx2
31 May 16
Neos Therapeutics Appoints Juergen Martens as Chief Technology and Operations Officer
12:00am
8-K
jfwqxria
16 May 16
Neos Therapeutics Announces Closing of $60 Million Term Debt Financing and First Quarter 2016 Financial Results
12:00am
DEFA14A
xgte9zi
27 Apr 16
Additional proxy soliciting materials
12:00am
DEF 14A
hsbmxrfs
27 Apr 16
Definitive proxy
12:00am
S-8
zcattlfh9gwvmmtkw
18 Mar 16
Registration of securities for employees
12:00am
10-K
bzsejs8eq5afbq
18 Mar 16
Annual report
12:00am
8-K
wohma
17 Mar 16
Neos Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
12:00am
RW
097wnd lpzrw8b7vmk6
8 Feb 16
Registration withdrawal request
12:00am
8-K
p4bl23q i8m
3 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
mrvvynf
29 Jan 16
Results of Operations and Financial Condition
12:00am
8-K
w0g yxfmddna
28 Jan 16
Neos Therapeutics Announces FDA Approval of
12:00am